Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Current Leases (2023 - 2025)

Connect Biopharma Holdings' Current Leases history spans 3 years, with the latest figure at $336000.0 for Q3 2025.

  • For Q3 2025, Current Leases changed N/A year-over-year to $336000.0; the TTM value through Sep 2025 reached $336000.0, changed N/A, while the annual FY2024 figure was $154000.0, 45.96% down from the prior year.
  • Current Leases for Q3 2025 was $336000.0 at Connect Biopharma Holdings, down from $350000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $350000.0 in Q2 2025 and bottomed at $154000.0 in Q4 2024.
  • The 3-year median for Current Leases is $336000.0 (2025), against an average of $294200.0.
  • The largest YoY upside for Current Leases was 45.96% in 2024 against a maximum downside of 45.96% in 2024.
  • A 3-year view of Current Leases shows it stood at $285000.0 in 2023, then tumbled by 45.96% to $154000.0 in 2024, then skyrocketed by 118.18% to $336000.0 in 2025.
  • Per Business Quant, the three most recent readings for CNTB's Current Leases are $336000.0 (Q3 2025), $350000.0 (Q2 2025), and $346000.0 (Q1 2025).